1. Mehler PS. Clinical practice. Bulimia nervosa. N Engl J Med 2003;349(9):875-81.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed, text rev). Washington, DC: American Psychiatric Association,2000.
3. Fisher M. The course and outcome of eating disorders in adults and in adolescents: a review. Adolesc Med 2003;14(1):149-58.
4. Fairburn CG, Norman PA, Welch SL, et al. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry 1995;52(4):304-12.
5. Hudson JI, Pope HG, Jr, Yurgelun-Todd D, et al. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry 1987;144(10):1283-7.
6. Hudson JI, Pope HG, Jr. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990;147(5):552-64.
7. Hudson JI, Mangweth B, Pope HG, Jr, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003;60:170-7.
8. Hudson JI, Laird NM, Betensky RA, et al. Multivariate logistic regression for familial aggregation of two disorders: II. Analysis of studies of eating and mood disorders. Am J Epidemiology 2001;153(5):506-14.
9. Mangweth B, Hudson JI, Pope HG, Jr, et al. Family study of the aggregation of eating disorders and mood disorders. Psychol Med (in press).
10. Hudson JI, Pope HG, Jr, Carter WP. Pharmacologic therapy of bulimia nervosa. In: Goldstein D (ed). The management of eating disorders and obesity (2nd ed) Totowa, NJ: Humana Press, Inc.(in press).
11. Pope HG, Jr, Hudson JI, Nixon RA, Herridge PL. The epidemiology of ipecac abuse. N Engl J Med 1986;14(4):245-6.
12. Hay PJ, Bacaltchuk J. Psychotherapy for bulimia nervosa and binging. Cochrane Database Syst Rev 2003;(1):CD000562.-
13. Bacaltchuk J, Hay P. Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database Syst Rev 2001;(4):CD003391.-
14. Crow S, Mussell MP, Peterson C, et al. Prior treatment received by patients with bulimia nervosa. Int J Eating Disord 1999;25(1):39-44.
15. Fluoxetine Bulimia Collaborative Study Group Fluoxetine in the treatment of bulimia nervosa: a multicenter placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139-47.
16. Hoopes S, Reimherr F, Hedges D, et al. Part 1:Topiramate in the treatment of bulimia nervosa: a randomized, double-blind, placebocontrolled trial. J Clin Psychiatry (in press).
17. Horne RL, Ferguson JM, Pope HG, Jr, et al. Treatment of bulimia with bupropion: a controlled multi-center trial. J Clin Psychiatry 1988;49(7):262-6.
18. Pope HG, Jr, McElroy SL, Keck PE, Jr, Hudson JI. Long-term pharmacotherapy of bulimia nervosa. J Clin Psychopharmacol 1989;9(5):385-6.
19. Fairburn CG, Harrison PJ. Eating disorders. Lancet 2003;361(9355):407-16.
20. Pope HG, Jr, Hudson JI. “Recovered memory” therapy for eating disorders: implications of the Ramona verdict. Int J Eat Disord 1996;19(2):139-45.
21. Pope HG, Jr, Hudson JI. Does childhood sexual abuse cause adult psychiatric disorders? Essentials of methodology. J Psychiatry Law 1995;Fall:363-81.
22. Pope HG, Jr, Oliva PS, Hudson JI. Repressed memories. The scientific status of research on repressed memories. In: Faigman DL, Kaye DH, Saks MJ, Sanders J (eds). Science in the law: social and behavioral science issues St. Paul, MN: West Group, 2002;487-526.
23. Cannell J, Hudson JI, Pope HG, Jr. Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law 2001;29(2):138-47.
24. Hudson JI, Chase EA, Pope HG, Jr. Eye movement desensitization and reprocessing in eating disorders: caution against premature acceptance. Int J Eat Disord 1998;23:1-5.
25. McNally RJ. EMDR and mesmerism: a comparative historical analysis. J Anxiety Disord 1999;13(1-2):225-36.